Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 76 to 90 of 544 results for iv

  1. Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatin (TA402)

    Evidence-based recommendations on pemetrexed (Alimta) for locally advanced or metastatic non-squamous non-small-cell lung cancer in adults who have had pemetrexed and cisplatin.

    Technology appraisal guidance
    Published
    24 August 2016
    View recommendations

    Sections for TA402

  2. VIDAvision for lung volume analysis in emphysema (MIB148)

    NICE has developed a medtech innovation briefing (MIB) on VIDAvision for lung volume analysis in emphysema .

    Medtech innovation briefing
    Published
    5 June 2018

  3. Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancer (TA569)

    Evidence-based recommendations on pertuzumab (Perjeta) for adjuvant treatment of HER2-positive early stage breast cancer in adults.

    Technology appraisal guidance
    Published
    20 March 2019
    View recommendations

    Sections for TA569

  4. Superior rectal artery embolisation for haemorrhoids (IPG627)

    Evidence-based recommendations on superior rectal artery embolisation for haemorrhoids in adults. This involves blocking the blood vessels supplying the haemorrhoids with tiny plastic particles or metal coils.

    Interventional procedures guidance
    Published
    29 August 2018
    View recommendations

    Sections for IPG627

  5. Laparoscopic hysterectomy (including laparoscopic total hysterectomy and laparoscopically assisted vaginal hysterectomy) for endometrial cancer (IPG356)

    Evidence-based recommendations on laparoscopic hysterectomy (including laparoscopic total hysterectomy and laparoscopically assisted vaginal hysterectomy) for endometrial cancer. This involves removing the uterus through several small cuts in the abdomen (keyhole surgery), with the aid of an internal telescope and camera.

    Interventional procedures guidance
    Published
    22 September 2010
    View recommendations

    Sections for IPG356

  6. Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia (TA119)

    Evidence-based recommendations on fludarabine monotherapy for untreated chronic lymphocytic leukaemia in adults.

    Technology appraisal guidance
    Published
    28 February 2007
    View recommendations

    Sections for TA119

  7. Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the knee (TA508)

    Evidence-based recommendations on autologous chondrocyte implantation using chondrosphere (Spherox) for treating symptomatic articular cartilage defects of the knee in adults.

    Technology appraisal guidance
    Published
    7 March 2018
    View recommendations

    Sections for TA508

  8. The OPTIMIZER smart system for managing heart failure (MIB186)

    NICE has developed a medtech innovation briefing (MIB) on the OPTIMIZER smart system for managing heart failure .

    Medtech innovation briefing
    Published
    27 June 2019

  9. Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer (TA258)

    Evidence-based recommendations on erlotinib (Tarceva) for treating EGFR-TK-positive non-small-cell lung cancer in adults.

    Technology appraisal guidance
    Published
    27 June 2012
    View recommendations

    Sections for TA258

  10. Ipilimumab for the adjuvant treatment of completely resected stage IV or high risk stage III melanoma [ID721]

    Discontinued [GID-TAG479]

    Technology appraisal guidance
    Discontinued

  11. Alcohol-use disorders: diagnosis and management of physical complications (CG100)

    This guideline covers care for adults and young people (aged 10 years and older) with physical health problems that are completely or partly caused by an alcohol-use disorder. It aims to improve the health of people with alcohol-use disorders by providing recommendations on managing acute alcohol withdrawal and treating alcohol-related conditions.

    Clinical guideline
    Last updated
    12 April 2017
    View recommendations

    Sections for CG100

  12. Electrotherapy for the treatment of haemorrhoids (IPG525)

    Evidence-based recommendations on electrotherapy for treating grade I to III haemorrhoids in adults. This involves using electric current to shrink the haemorrhoids.

    Interventional procedures guidance
    Published
    26 June 2015
    View recommendations

    Sections for IPG525

  13. NICE CG32 Refeeding Guidelines: Retrospective audit comparing dietetic and medical practice of vitamin prescriptions, blood checks and K+, PO43- & Mg2+ replacement including discharge medications

    effective and in orally fed patients £4.68 was being wasted over three days due to IV medications being recommended Therefore this audit...

    Shared learning
    Published
    18 April 2018

  14. Utilising the skills of the clinical pharmacist within the MDT for improved medicines optimisation

    Prescribing of gentamicin to AMG protocol for intra-abdominal sepsis. Switch from IV to PO. Significant interventions Patient treated...

    Shared learning
    Published
    1 May 2018

  15. Incorporating NICE guidance into the Sepsis Care Pathway at Tameside: improving patient care, safety and mortality in relation to sepsis

    settings, 1.7 Antibiotic treatment in people with suspected sepsis, 1.8 Intravenous fluids in people with suspected sepsis, 1.9 Using...

    Shared learning
    Last updated
    18 May 2018